Program

Program Wednesday, June 4, 2014

7:15 AM - 8:15 AM
EDUCATIONAL SYMPOSIA
7:15 AM - 8:15 AM
Room: Room 518abc (5th Floor)
COMMUNICATING THE VALUE OF INNOVATION FOR ONCOLOGY THERAPY – THE ROAD AHEAD

(Sponsored by Truven Health Analytics)

8:30 AM - 2:45 PM
RESEARCH POSTER PRESENTATIONS - SESSION V
8:30 AM - 9:30 AM
ISSUE PANELS - SESSION IV
Health Policy Development Using Outcomes Research Issues
8:30 AM - 9:30 AM
Room: Room 518abc (5th Floor)

IP16: PERSONALIZED MEDICINE IN THE ERA OF BIG DATA: HOW WILL THIS AFFECT YOU?

Moderator:

Amalia M. Issa, PhD, MPH, Professor & Chair, Department of Health Policy and Public Health & Program in Personalized Medicine & Targeted Therapeutics, University of the Sciences in Philadelphia, Philadelphia, PA, USA

Panelists:

Gillian Bartlett-Esquilant, PhD, Associate Professor, Department of Family Medicine, McGill University, Montreal, QC, Canada

Martin Dawes, MD, FRCGP, Royal Canadian Legion Professor & Head, Department of Family Practice, University of British Columbia, Vancouver, BC, Canada

Gary E. Marchant, JD, PhD, Regents' Professor of Law, Sandra Day O’Connor College of Law, Arizona State University, Tempe, AZ, USA


8:30 AM - 9:30 AM
Room: Room 519ab (5th Floor)

IP17: THE AFFORDABLE CARE ACT: WILL IT HELP OR HARM THE LANDSCAPE FOR BIOMEDICAL INNOVATION AND TECHNOLOGY?

Moderator:

Amitabh Chandra, PhD, Professor of Public Policy, John F Kennedy School of Government, Harvard University, Cambridge, MA, USA

Panelists:

Michael Chernew, PhD, Leonard Schaeffer Professor of Health Care Policy, Harvard Medical School, Boston, MA, USA

Anup Malani, PhD, JD, Lee and Brena Freeman Professor, University of Chicago Law School, Chicago, IL, USA

Darius N. Lakdawalla, PhD, Professor, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, University of Southern California, Los Angeles, CA, USA


8:30 AM - 9:30 AM
Room: Room 520a (5th Floor)

IP18: RISK SHARING FOR MEDICAL DEVICES: HAS THE TIME COME?

Moderator:

Susan Garfield, DrPH, Senior Vice President, Market Access, Health, GfK Market Access, Wayland, MA, USA

Panelists:

Michael Ferguson, PhD, Director, Health Economics and Comparative Effectiveness Research, Health Economics & Reimbursement, Boston Scientific, Natick, MA, USA

David Ertel, MBA, MPH, Chief Financial Officer, Einstein Healthcare, Philadelphia, PA, USA

Maria Lopes, MD, Chief Marketing Officer, Geisenger Health Systems, Danville, PA, USA


8:30 AM - 9:30 AM
Room: Room 520b (5th Floor)

IP19: CAN MOBILE HEALTH REVOLUTIONIZE HEALTH OUTCOMES RESEARCH?

Moderator:

Kathleen E. Hughes, MBA, Vice President, Health Economics and Outcomes Research, Avalere Health LLC, Washington, DC, USA

Panelists:

Betsy J Lahue, MPH, Vice President, Health Economics and Outcomes Research, Becton Dickinson, Franklin Lakes, NJ, USA

Yarmela Pavlovic, JD, Partner, Hogan Lovells US LLP, Philadelphia, PA, USA

Jo Carol Hiatt, MD, MBA, Chair, National Product Council, and Assistant Medical Director, Southern California Permanente Medical Group Business Administration, Pasadena, CA, USA


8:30 AM - 9:30 AM
Room: Room 520c (5th Floor)

IP20: AUSTERITY MEASURES VERSUS EARLY ACCESS TO INNOVATIVE TREATMENT: HOW TO STRIKE A BALANCE BETWEEN PATIENTS' NEEDS AND BUDGET AVAILABILITIES?

Moderator:

Vladimir Zah, Health Economist and Founder, ZRx Outcomes Research Inc., Belgrade, Serbia and Montenegro

Panelists:

Andrea Manca, PhD, MSc, Professor, Centre for Health Economics, University of York, York, UK

Zoltan Kalo, MD, MSc, PhD, Chief Executive Officer, Syreon Research Institute, Budapest, Hungary

Katarzyna Kolasa, PhD, Senior Research Fellow, Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland

9:30 AM - 9:45 AM
BREAK, EXHIBITS & RESEARCH POSTER PRESENTATIONS VIEWING - SESSION V
9:45 AM - 11:00 AM
WELCOME & THIRD PLENARY SESSION
WELCOME
William H. Crown, PhD bio
2013-2014 ISPOR President and Chief Scientific Officer, Optum Labs, Cambridge, MA, USA
THIRD PLENARY SESSION: TO WHAT EXTENT SHOULD VALUE FOR MONEY DERIVED FROM HEALTH ECONOMIC ANALYSIS BE USED IN HEALTH CARE POLICY DECISION MAKING?
This session will focus on whether or how value for money is being used in health care policy decision making in government and private insurance companies. The pros and cons of the different types of economic analysis currently used to determine value for money as well as ethical issues will be debated.
Moderator: Don Husereau, MSc, BScPharm bio
Senior Associate, Institute of Health Economics, Adjunct Professor, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
Speaker: Tony Culyer, Hon DEcon, Hon FRCP, FRSA, FMedSci bio
Ontario Research Chair in Health Policy and System Design, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
Speaker: Colleen M. Flood, LLM, SJD bio
Canada Research Chair in Health Law and Policy, Faculty of Law, University of Toronto, Toronto, ON, Canada
Speaker: Honourable Minister Fred Horne bio
Government of Alberta, Ministry of Health, Edmonton, AB, Canada
11:00 AM - 11:30 AM
ISPOR 19th INTERNATIONAL MEETING RESEARCH PRESENTATION AWARDS
ISPOR SERVICE AND DISTINGUISHED SERVICE AWARDS
Presented by: William H. Crown, PhD bio
2013-2014 ISPOR President and Chief Scientific Officer, Optum Labs, Cambridge, MA, USA
ISPOR STUDENT AWARDS
Presented by: Zeba M. Khan, RPh, PhD
ISPOR Student Network Advisor and Vice President, Strategic Market Access & Policy, Celgene Corporation, Summit, NJ, USA
ISPOR BEST PODIUM PRESENTATIONS
Presented by: Jean Lachaine, PhD
Professor, Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada
ISPOR BEST POSTER PRESENTATIONS
Presented by: Onur Baser, PhD, MS, MA
President, STATinMED and Adjunct Professor of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
PhRMA FOUNDATION 2014 AWARDS
Presented by: Jean Paul Gagnon, PhD, RPh
Chairman of the PhRMA Foundation Health Outcomes and CER Advisory Committees and Health Policy Consultant, Washington, DC, USA
11:30 AM - 1:45 PM
LUNCH, EXHIBITS & RESEARCH POSTER PRESENTATIONS VIEWING - SESSION V
11:45 AM - 12:45 PM
EDUCATIONAL SYMPOSIA
11:45 AM - 12:45 PM
Room: Room 518abc (5th Floor)
BRIDGING TO COMPARATIVE EFFECTIVENESS

(Sponsored by LASER ANALYTICA)

12:45 PM - 1:45 PM
POSTER AUTHOR DISCUSSION HOUR - SESSION V
1:45 PM - 2:45 PM
WORKSHOPS - SESSION IV
Clinical Outcomes Research
1:45 PM - 2:45 PM
Room: Room 518abc (5th Floor)
W22: METHODOLOGICAL CHOICES FOR PROPENSITY SCORE MATCHING AND THEIR CONSEQUENCES
Discussion Leaders:

Samuel Aballéa, PhD, Vice President, Health Economics & Outcomes Research, Creativ-Ceutical, Paris, France

Firas M. Dabbous, MS, PhD candidate, Public Health and Epidemiology, University of Illinois at Chicago, Chicago, IL, USA

Katia Thokagevistk, MSc, Senior Analyst, Health Economics & Outcomes Research, Creativ-Ceutical USA, Chicago, IL, USA

Economic Outcomes Research
1:45 PM - 2:45 PM
Room: Room 519ab (5th Floor)
W23: AN ALTERNATIVE TO HAZARDOUS HAZARDS ASSUMPTIONS: EVIDENCE SYNTHESIS FOR SURVIVAL OUTCOMES IN AN ECONOMIC EVALUATION OF AN ONCOLOGY DRUG
Discussion Leaders:

Jeroen P Jansen, PhD, Director, Redwood Outcomes, San Francisco, CA, USA

Jeffrey S. Hoch, PhD, Associate Professor, Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Christopher O'Regan, MSc, Head of Health Technology Assessment & Outcomes, Merck Sharp & Dohme Limited, Hertfordshire, UK

Health Care Policy Development Using Outcomes Research
1:45 PM - 2:45 PM
Room: Room 520a (5th Floor)
W24: THE ROLE OF PATIENT-REPORTED OUTCOMES DATA IN HEALTH CARE DECISION MAKING IN RARE DISEASES
Discussion Leaders:

Margaret K. Vernon, PhD, Senior Research Scientist & EU Director, Outcomes Research, Evidera, London, UK

Philip Ruff, PhD, Director, Global Market Access, Shire, Lexington, MA, USA

Isabel Kalofonos, MBA, Director, Global Market Access, Shire, Lexington, MA, USA

Asha Hareendran, PhD, Senior Research Scientist, Outcomes Research, Evidera, London, UK

Patient-Reported Outcomes & Patient Preference Research
1:45 PM - 2:45 PM
Room: Room 520b (5th Floor)
W25: GOOD PRACTICE GUIDELINES FOR QALYs: ISPOR'S DANGEROUS OMISSION?
Discussion Leaders:

Christopher McCabe, MSc, PhD, Professor, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada

John Brazier, PhD, Professor, Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK

David M Meads, MSc, Lecturer in Health Economics, Academic Unit of Health Economics, University of Leeds, Leeds, UK

Use of Real World Data
1:45 PM - 2:45 PM
Room: Room 520c (5th Floor)
W26: BIG DATA AND LITTLE DISEASES: MEETING THE CHALLENGES FOR RARE DISEASE OUTCOMES RESEARCH
Discussion Leaders:

Alaa Hamed, MD, MPH, MBA, Director Rare Diseases, Genzyme POME, Genzyme, a Sanofi Company, Cambridge, MA, USA

Alexandra Ward, PhD, MRPharmS, Senior Research Scientist, Evidera, Lexington, MA, USA

Sumeet Panjabi, PhD, Director, Global Health Economics, Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA

Kathleen W. Wyrwich, PhD, Senior Research Leader, Evidera, Bethesda, MD, USA

2:45 PM - 3:00 PM
BREAK & EXHIBITS VIEWING - SESSION V
3:00 PM - 4:00 PM
WORKSHOPS - SESSION V
Economic Outcomes Research
3:00 PM - 4:00 PM
Room: Room 520c (5th Floor)
W27: EXPECTED VALUE OF PERFECT INFORMATION: ACTIVE LEARNING THROUGH USER-FRIENDLY COMPUTATIONS, DISPLAYS, AND APPLICATION DISCUSSIONS
Discussion Leaders:

R. Brett McQueen, PhD, Post Doctoral Fellow, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Eldon Spackman, PhD, Research Fellow, Centre for Health Economics, The University of York, Heslington, York, UK

Jonathan D Campbell, PhD, Assistant Professor, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Health Care Policy Development Using Outcomes Research
3:00 PM - 4:00 PM
Room: Room 519ab (5th Floor)
W28: HOW TO ADDRESS UNCERTAINTY RELATED TO TRANSFERABILITY OF CLINICAL TRIAL FINDINGS TO CLINICAL PRACTICE?
Discussion Leaders:

Mondher Toumi, MD, PhD, Professor, Market Access, University Claude Bernard Lyon 1, Lyon, France

Asa Kornfeld, MSc, Director, Pricing and Market Access, Creativ-Ceutical, Paris, France

Pascal Auquier, MD, PhD, Professor & Hospital Practitioner, Department of Public Health, Timone University Hospital, Marseille, France

Isaac AO Odeyemi, DVM, PhD, MBA, MSc, Senior Director, Health Economics & Outcomes Research, Astellas Pharma Europe Ltd, Chertsey, UK


3:00 PM - 4:00 PM
Room: Room 520a (5th Floor)
W29: THE NEXT FRONTIER: EXPLORING ACCESS EVOLUTION IN THE MIDDLE EAST GULF COOPERATION COUNCIL MARKETS – HEALTH TECHNOLOGY ASSESSMENT, REGIONAL PROCUREMENT, AND VALUE FOR MONEY
Discussion Leaders:

Meghan Gallagher, Director, Global Health Economics and Outcomes Research, Oncology, Sanofi, Cambridge, MA, USA

Cyrus A. Chowdhury, Chief Executive Officer, CBPartners, New York, NY, USA

Husein Reka, MSc, Manager, National Health Authority, State of Qatar, Doha, Qatar

Ola Ghaleb Al Ahdab, PhD, Pharmaceutical Advisor, Registration and Drug Control Department, Ministry of Health, Abu Dhabi, United Arab Emirates

Patient-Reported Outcomes & Patient Preference Research
3:00 PM - 4:00 PM
Room: Room 520b (5th Floor)
W30: QUANTITATIVE CHALLENGES FACING PATIENT-CENTERED OUTCOMES RESEARCH
Discussion Leaders:

Wen-Hung Chen, PhD, Director of Psychometrics, Patient-Reported Outcomes, RTI Health Solutions, Research Triangle Park, NC, USA

Lauren Moore Nelson, PhD, Director of Psychometrics, Patient-Reported Outcomes, RTI Health Solutions, Research Triangle Park, NC, USA

Lori Davis McLeod, PhD, Head of Psychometrics, Patient-Reported Outcomes, RTI Health Solutions, Research Triangle Park, NC, USA

Maria Orlando Edelen, PhD, Senior Behavioral Scientist, RAND Corporation, Boston, MA, USA

Use of Real World Data
3:00 PM - 4:00 PM
Room: Room 518abc (5th Floor)
W31: EVALUATION OF THE BARRIERS AND OPPORTUNITIES OF BIG DATA IN HEALTH OUTCOMES RESEARCH
Discussion Leaders:

Diana Brixner, PhD, RPh, FAMCP, Professor & Chair, Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA

Carl V Asche, PhD, Director, Center for Outcomes Research & Research Professor, Department of Medicine, University of Illinois College of Medicine, Peoria, IL, USA

Maggie Gunter, PhD, Director of Medical Outcomes Research, Lovelace Respiratory Research Institute, Albuquerque, NM, USA

Manuel Prado, BA, President & CEO, Real Health Data, Santa Cruz, CA, USA

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2016 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.